DE2412520C2 - Tricyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende Präparate - Google Patents

Tricyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende Präparate

Info

Publication number
DE2412520C2
DE2412520C2 DE2412520A DE2412520A DE2412520C2 DE 2412520 C2 DE2412520 C2 DE 2412520C2 DE 2412520 A DE2412520 A DE 2412520A DE 2412520 A DE2412520 A DE 2412520A DE 2412520 C2 DE2412520 C2 DE 2412520C2
Authority
DE
Germany
Prior art keywords
general formula
fluoro
compound
acid
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2412520A
Other languages
German (de)
English (en)
Other versions
DE2412520A1 (de
Inventor
Max Dr. Gerecke
Jean-Pierre Dr. Le Plessis Robinson Kaplan
Emilio Dr. Reinach Kyburz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH460673A external-priority patent/CH585224A5/xx
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2412520A1 publication Critical patent/DE2412520A1/de
Application granted granted Critical
Publication of DE2412520C2 publication Critical patent/DE2412520C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/14—[b,f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DE2412520A 1973-03-30 1974-03-15 Tricyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende Präparate Expired DE2412520C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH460673A CH585224A5 (en) 1973-03-30 1973-03-30 Central-inhibitory and neuroleptic fluoro- tricyclic cpds. - prepd. by reacting a 10-halo-fluoro-substd. dibenzothiepin with a substd piperazine
CH56874 1974-01-16

Publications (2)

Publication Number Publication Date
DE2412520A1 DE2412520A1 (de) 1974-10-10
DE2412520C2 true DE2412520C2 (de) 1982-09-16

Family

ID=25684981

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2412520A Expired DE2412520C2 (de) 1973-03-30 1974-03-15 Tricyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende Präparate

Country Status (5)

Country Link
US (1) US3966737A (cg-RX-API-DMAC10.html)
JP (1) JPS49135983A (cg-RX-API-DMAC10.html)
DE (1) DE2412520C2 (cg-RX-API-DMAC10.html)
FR (1) FR2223039B1 (cg-RX-API-DMAC10.html)
GB (1) GB1435037A (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011222A (en) * 1973-03-30 1977-03-08 Hoffmann-La Roche Inc. Fluoro-substituted dibenzo[b,f]thiepins
US4105664A (en) * 1974-01-04 1978-08-08 Hoffmann-La Roche Inc. Dibenz[b,f]oxepin derivatives
US3996229A (en) * 1974-01-14 1976-12-07 Hoffmann-La Roche Inc. 1-[10,11-Dihydro-dibenzo[b,f]-thiepin-10-yl]-4-(alkynylalkyl)-piperazines
FI753625A7 (cg-RX-API-DMAC10.html) * 1975-01-06 1976-07-07 Spofa Vereinigte Pharma Werke
CH613205A5 (cg-RX-API-DMAC10.html) * 1975-06-06 1979-09-14 Hoffmann La Roche
CS196893B1 (en) * 1977-12-22 1980-04-30 Miroslav Protiva 3-fluor-10-piperazino-8-substituted 10,11-dihydro-dibenzothiepines
GB0415320D0 (en) * 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH456636A (de) 1964-09-17 1968-07-31 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung von neuen Aminen
NL137032C (cg-RX-API-DMAC10.html) * 1967-03-28 Richardson Merrell Spa
FR1558916A (cg-RX-API-DMAC10.html) * 1967-05-23 1969-03-07
CH493558A (de) * 1968-02-21 1970-07-15 Geigy Ag J R Verfahren zur Herstellung von neuen Imidazolidinonderivaten
GB1251774A (cg-RX-API-DMAC10.html) * 1969-03-24 1971-10-27
CH550189A (de) * 1971-01-08 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren.

Also Published As

Publication number Publication date
US3966737A (en) 1976-06-29
DE2412520A1 (de) 1974-10-10
GB1435037A (en) 1976-05-12
FR2223039A1 (cg-RX-API-DMAC10.html) 1974-10-25
FR2223039B1 (cg-RX-API-DMAC10.html) 1977-07-01
JPS49135983A (cg-RX-API-DMAC10.html) 1974-12-27

Similar Documents

Publication Publication Date Title
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE2614406C2 (cg-RX-API-DMAC10.html)
DE2065636A1 (de) Neue tricyclische verbindungen
DE2929777A1 (de) N-alkylimidazolderivate, verfahren zu ihrer herstellung und solche enthaltende arzneimittel
DE2336130A1 (de) Tricyclische verbindungen
AT368131B (de) Verfahren zur herstellung von neuen 9-aminoalkyl- fluorenen und von deren salzen
DE2162011C3 (de) 2-Phenyl-3-(4-methyl-piperazinocarbonyloxy)-1-isoindolinon-derivate, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69720021T2 (de) 1,4-disubstituierte piperazine
DE2412520C2 (de) Tricyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende Präparate
DE2426149B2 (de) 7-Fluor-substituierte Phenothiazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE3209304C2 (cg-RX-API-DMAC10.html)
DE3305495A1 (de) Piperazin- und homopiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
AT391316B (de) Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2359359C3 (de) Fluor-substituierte Thioxanthene, Verfahren zu ihrer Herstellung sowie diese enthaltende neuroleptische Mittel
DE1905353C3 (de) 2-Benzylimidazolinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen
DE2366237C2 (de) 4-[2-(2-Methoxynicotinamido)äthyl]-1-piperidinsulfonamid
DE2833892C2 (de) 12H-Dibenzo[d,g][1,3,6]dioxazocinderivate, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben
DE2012667C3 (de) 3- (4-substituierte-1-Piperazinyl)-carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate
DE2412521A1 (de) Tricyclische verbindungen
CH513806A (de) Verfahren zur Herstellung von tricyclischen Verbindungen
AT344182B (de) Verfahren zur herstellung von neuen 10,11-dihydro-dibenzo(b,f)thiepin-derivaten und und deren salzen
DE2461137A1 (de) Tricyclische verbindungen
AT295516B (de) Verfahren zur Herstellung neuer cyclischer Amidine und ihrer Salze
DE2557446C2 (de) 1-(2'-Aroyl-äth-1'-yl)-2-(4''-acetamido-piperazin-1''-yl-methyl)-benzimidazole, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2158959A1 (de) Neue Imidazohdinonderivate und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8339 Ceased/non-payment of the annual fee